Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Cancer Female × palbociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 73 Neoplasm Metastasis 6 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Neoplasms 3 Ovarian Neoplasms 2 Melanoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Untreated Operable Early Breast Cancer 1 Testicular Neoplasms 1 Teratoma 1 Somatostatinoma 1 Solid Tumors 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Squamous Cell Lung Carcinoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Patient Acceptance of Health Care 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1

Interventions

Exercise 3 Paclitaxel 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Thioctic Acid 1 Surveys and Questionnaires 1 Sodium Chloride 1 Ropivacaine 1 Radiofrequency Ablation 1 Neoadjuvant Therapy 1 Methotrexate 1 Metformin 1 Mastectomy 1 Electrochemotherapy 1 Educational Status 1 Drug Delivery Systems 1 Doxorubicin 1 Diet 1 Dexmedetomidine 1 Control Groups 1 Caloric Restriction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03065621 2023-04-19

NeoRHEA

Jules Bordet Institute

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡